Subclinical hypothyroidism: Comparison of adhesion molecule levels before and after levothyroxine therapy
dc.contributor.author | Bilgir, F | |
dc.contributor.author | Bilgir, O | |
dc.contributor.author | Calan, M | |
dc.contributor.author | Calan, O | |
dc.contributor.author | Isikyakar, T | |
dc.date.accessioned | 2024-07-18T12:05:14Z | |
dc.date.available | 2024-07-18T12:05:14Z | |
dc.description.abstract | Objective: Adhesion molecules are involved in inflammation, atherosclerosis and malignancy. This study measured levels of adhesion molecules before and after levothyroxine therapy in patients with subclinical hypothyroidism (SHO). Methods: Levels of soluble (s) intracellular adhesion molecule (ICAM)-1, s vascular cell adhesion molecule (sVCAM) VCAM-1 and sE-selectin were analysed in patients diagnosed with SHO, prior to administration of 50 mg/day levothyroxine orally for 3 months. Subsequently, levels of sICAM-1, sVCAM-1 and sE-selectin were reanalysed then compared with the pretreatment levels. Results: In 30 patients with SHO, levels of sICAM-1 were found to be significantly higher than those in healthy controls, (P = 0.001). Post-treatment sICAM-1 levels were significantly lower than pretreatment levels (P = 0.001). No significant differences were found in sVCAM-1 or sE-selectin levels between healthy controls and patients with SHO before treatment, or between patients with SHO pre- and post-treatment. Conclusions: Patients with SHO had significantly higher levels of sICAM-1 compared with controls. Levels became normal after treatment with levothyroxine. These findings emphasize the need for levothyroxine therapy in cases of SHO to normalize sICAM-1 levels. Such treatment helps to prevent the future development of atherosclerosis or cancer. | |
dc.identifier.issn | 0300-0605 | |
dc.identifier.other | 1473-2300 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/9626 | |
dc.language.iso | English | |
dc.publisher | SAGE PUBLICATIONS LTD | |
dc.subject | SE-SELECTIN LEVELS | |
dc.subject | THYROID-DISORDERS | |
dc.subject | CANCER | |
dc.subject | REPLACEMENT | |
dc.subject | EXPRESSION | |
dc.subject | DYSFUNCTION | |
dc.subject | PREVALENCE | |
dc.subject | COMMUNITY | |
dc.subject | ICAM-1 | |
dc.subject | WOMEN | |
dc.title | Subclinical hypothyroidism: Comparison of adhesion molecule levels before and after levothyroxine therapy | |
dc.type | Article |